CTRI/2017/10/010110已完成3 期
A single-centre randomized, open-label trial to determine the effect of giving 12% carbohydrate -containing clear fluid orally 2 hours before procedure on recovery profile in Children.
Archana A Bharadwaj0 个研究点目标入组 101 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 101
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ASA physical status 1 and 2
- •Scheduled for short surgeries, duration upto 2 hours
排除标准
- •Active uncontrolled GERD, active vomiting, not NPO state, known allergy to midazolam, psychotropic medication use, active upper respiratory tract infection, posted for a Gastrointestinal surgery.
研究者
相似试验
招募中
2 期
Safety and Efficacy of Eculizumab to prevent antibody mediated rejection in sensitized kidney transplant recipients from a deceased donorkidney transplantRenal and Urogenital - Kidney diseaseACTRN12612000333819Alexion Pharmaceuticals Inc40
已完成
3 期
A randomized, open label, multicentre trial to define the most effective haemoglobin concentration to start erythropoietin beta (neoRecormon) therapy in anaemic subjects with lymphoproliferative malignancy receiving chemotherapy *REPOS Study*anemiaNL-OMON34234HagaZiekenhuis150
已完成
不适用
A study to compare spinal cord stimulator implantation with laser treatment of the heart in patients with chronic anginaChronic angina pectorisCirculatory SystemAngina pectorisISRCTN09648950Medtronic Sàrl (Switzerland)68
进行中（未招募）
不适用
A randomized, open label, multicentre trial to define the most effective haemoglobin concentration to start erythropoietin beta (neoRecormon) therapy in anaemic subjects with lymphoproliferative malignancy receivin chemotherapyREPOSstudy - Repos studyAnemia in cancer patientsEUCTR2006-003727-37-NLHaga Teaching Hospital150
已完成
3 期
Single arm trial with afatinib to assess its safety in patients with non-small cell lung cancer(NSCLC)harboring EGFR mutation(s)CTRI/2014/08/004907Boehringer Ingelheim Hongkong50